Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 3'-untranslated regions (3'-UTRs) of pro-apoptotic messenger RNAs (mRNAs) are critical regulatory segments located immediately downstream of the protein-coding sequence. These regions contain specific binding sites for microRNAs (miRNAs) and RNA-binding proteins (RBPs) that dictate the stability, localization, and translation efficiency of the mRNA transcript (Source: Nature Reviews Genetics, PubMed: 28234320). In healthy cells, these UTRs ensure that pro-apoptotic proteins such as BIM, PUMA, and BAX are expressed at appropriate levels to maintain cellular homeostasis. However, in many cancers, oncogenic miRNAs (oncomiRs) are overexpressed and bind to these 3'-UTRs, leading to the silencing of pro-apoptotic signals and allowing the cell to evade programmed cell death (Source: Cell, PubMed: 19188480). Therapeutic strategies targeting these regions include the use of antisense oligonucleotides (ASOs) or 'target site blockers' that physically shield the 3'-UTR from inhibitory miRNAs, thereby restoring the expression of cell death-inducing proteins. Additionally, miRNA mimics and small molecules are being developed to modulate these interactions, offering a novel approach to treating malignancies and other diseases characterized by dysregulated apoptosis (Source: Nature Reviews Drug Discovery).
Restoration of pro-apoptotic protein expression by blocking miRNA-mediated repression or enhancing mRNA stability through targeted sequence binding.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-apoptotic messenger RNA 3'-untranslated regions (Pro-apoptotic mRNA 3'-UTRs).